Stay updated with breaking news from Marie Utter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) have earned an average rating of “Moderate Buy” from the nineteen analysts that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year […]
PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its price target decreased by Barclays from $57.00 to $48.00 in a research report sent to investors on Wednesday, The Fly reports. A number of other analysts also recently issued reports on PTCT. William Blair reiterated an outperform rating on shares of PTC Therapeutics in a report on […]
PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price lowered by stock analysts at Credit Suisse Group from $55.00 to $50.00 in a report issued on Wednesday, The Fly reports. Credit Suisse Group’s price objective would suggest a potential upside of 15.05% from the stock’s current price. PTCT has been the topic of a […]
StockNews.com assumed coverage on shares of PTC Therapeutics (NASDAQ:PTCT – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on PTCT. Morgan Stanley boosted their price target on PTC Therapeutics from $40.00 to […]
VNET Group restated their maintains rating on shares of PTC Therapeutics (NASDAQ:PTCT – Get Rating) in a research note issued to investors on Thursday morning, Benzinga reports. Several other analysts also recently issued reports on the company. Credit Suisse Group lifted their price target on PTC Therapeutics from $48.00 to $51.00 in a research note […]